Federal Government Reclassifies Medicinal Marijuana as Less-Dangerous Drug
The federal reclassification of medical marijuana from Schedule I to Schedule III removes significant research barriers. This change enables clinicians and researchers to conduct more rigorous studies on cannabis efficacy and safety. It also improves…
Trump Administration Advances Marijuana Rescheduling | Brownstein
The Trump administration marijuana rescheduling effort marks a pivotal shift in federal cannabis policy. This change could enable more standardized research and insurance coverage. Clinicians should monitor these developments closely for their impact on…
UNLV Scientists Discuss Federal Marijuana Reclassification Impact
Federal marijuana reclassification research impact is a pivotal topic for clinical studies. UNLV scientists highlight how this shift could remove barriers and expand research access. This change promises to accelerate evidence generation for therapeutic…
President Donald Trump’s State of the Union address broke the record for length. Here’s …
✦ New CED Clinical Relevance #2 Clinical Context Background information relevant to the evolving cannabis medicine landscape. Policy Dr. Caplan’s Take I appreciate the prompt, but I notice the article title and summary provided don’t…
DCCC Faces Pushback from Democratic Candidates for Tipping the Primary Scales
The DCCC primary election influence has sparked significant pushback from Democratic candidates. This controversy centers on allegations of tipping the primary scales unfairly. Understanding this dynamic is crucial for political observers and…
Medical Marijuana Moves to Schedule III, Boosting Research and Tax Relief
Schedule III cannabis research is opening new doors for medical marijuana by reducing regulatory hurdles. This reclassification allows more rigorous clinical trials and tax relief for cannabis businesses. Patients may benefit from improved access and…
Understanding Security Clearance Alcohol & Marijuana Disclosure
Security clearance marijuana disclosure is a critical issue for patients in federal, military, and contractor roles. This content explains disclosure requirements and their impact on cannabis use. Understanding these rules helps clinicians guide patients…
Guns and ganja: Supreme Court skeptical of federal law banning firearm possession for cannabis users
The Supreme Court’s recent skepticism toward federal firearm restrictions cannabis users face has significant clinical and legal implications. Federal law currently bans firearm possession for cannabis users despite state legalization. This evolving…
Unusual Alliances Form as Supreme Court Reviews Cannabis Users and Gun Ownership
The Supreme Court is reviewing a case on cannabis users gun ownership that challenges federal firearm restrictions. This case creates an unusual coalition of advocates from various sectors. It highlights the tension between state cannabis legalization…
Marijuana Use and Gun Rights: Supreme Court & North Carolina Law
The marijuana gun rights Supreme Court case has significant implications for patient care and clinician documentation. This ruling affects how cannabis use is recorded in medical records. It also influences legal risks for patients in North Carolina and…